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Abstract:
In this study, we examined the
association between microbubbles
formed in the circulationfrom a free
gas phase and symptoms of altitude
decompression sickness (DCS). In a
subgroup of 59 males of mean (S.D)
age 31.2 (5.8) years who developed
microbubbles during exposure to 26.59
kPa (4.3 psi) under simulated extra-
vehicular activities (EVA), symptoms
of DCS occurred in 24 (41%)
individuals. Spencer grade I
microbubbles occurred in 4 (7%), grade
II in 9 (15%), grade III in 15 (25%),
and grade IV in 31 (53%) of subjects.
Survival analysis Using Cox
proportional hazards regression
showed that individuals with >grade
III CMB showed 2.46 times (95%
confidence interval=1.26 to 5.34)
higher risk of symptoms. This
information is crucial for defining the
risk of DCS for inflight Doppler
monitoring under space EVA.
Altitude decompression
sickness (DCS) occurs when there
is acute reduction in ambient
pressure. The symptoms of DCS
are due to the formation of a free
gas phase (in the form of gas
microbubbles) in tissues during
decompression. Musculo-skeletal
pain of bends is the commonest
form of DCS in altitudeexposures.
In the space flight environment,
there is a risk of DCS when
astronauts decompress from the
normobaric shuttle pressure into
the hypobaric space suit pressure
(currently about 29.65 kPa [4.3
psi]) for extra-vehicular activities
(EVA). This risk is
counterbalanced by a judicious
combination of prior
denitrogenation and staged
decompression (1).
Studies on DCS are limited by
the duration of the test at reduced
pressure. Since only a proportion of
subjects tested develop symptoms,
the information on DCS is
generally incomplete or "censored".
Many studies employ Doppler
ultrasound monitoring of the
precordial area for detecting
circulating microbubbles (CMB).
Although the association between
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CMB and bends pain is not causal,
CMB are frequently monitored
during decompression.
In this paper, we examine
the association between CMB and
symptoms of DCS under simulated
EVA profiles.
Methoda"
The information on a subgroup
of 59 males who developed CMB
(out of 126 individuals) during
various decompression profiles to
29.65 kPa in the hypobaric
chamber were examined. The
studies involved direct ascent, as
well as staged decompression
procedures. All the subjects
breathed 100% oxygen at the final
pressure while performing
exercises simulating EVA for a
period of three to six hours (1).
They were monitored for CMB
using the precordial Doppler
technique, and graded on the
Spencer scale of 0 to IV for severity
(2). A 360-minute half-time tissue
ratio (TRseo) was calculated to
account for differences in
prebreathe period and staged
decompression events.
The distribution of individuals
with and without symptoms was
examined by using Kolmogorov-
Smirnov test or likelihood ratio chi-
square test, as appropriate.
Univariate survival curves were
described using pr0duct-limit
method. Differences in survival
curves were examined by using the
Mantel-Cox test statistic (3).
Multivariate analyses were carried
out using Cox proportional hazards
regression model (3,4) with
variables such as age, body mass
index (BMD, TRseo, time to
detection of CMB and maximum
grade of CMB as covariates. All
results with P-values of 0.05 and
below were considered as
significant.
Result&"
The mean (S.D.) age was 31.2
(5.8) years, BMI 23.7 (1.9), TRseo
1.72 (0.09), time to detection of
CMB 81.4 (61.8) minutes,
mArimum CMB grade 3.24 (0.95),
and time to symptoms 197.9
(104.6) minutes. Twenty-four
individuals (41%) presented with
symptoms of DCS. All symptoms
were mild, joint pain ("bends") and
no neurological or circulatory
complications were reported. The
distribution of individual
characteristics by symptom status
(present or absent) is given in
Table 1.
The symptom-free survival rates
for the group with various grades
of CMB are given in Table 2.
The Mantel-Cox test for trend
showed a significant difference
(P=0.004) among the groups with
various maximum CMB grades. It
may also be seen from the Table
that the cumulative survival rates
reduced as the maximum grade of
CMB was higher. Individuals with
higher grades of CMB showed
higher risk of symptoms.
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Table 1. Individual Distribution
By Symptom Status
Present Absent
n=24 n=35
Age (years)
BMI
TP_
Time to
CMB (rain)
Maximum
CMB grade*
_<III
>III
33.3
(6.4)
23.5
(1.9)
1.7
(0.1)
68.4
(57.5)
4 (17%)
20 (83%)
29.8
(4.8)
23.8
(1.9)
1.7
(0.I)
90.3
(63.9)
24 (69%)
11 (31%)
Values areMean (S.D.);BMl=Body Mass
Index;CMB=Circulating Microbubbles;
*P<0.05
Table2. Symptom-free Cumulative
Survival Rates
CMB
grades
I
II
III
IV
n DCS
4 2
9 0
15 2
31 11
Survival
(S.D.)
0.33
(0.27)
1.00
0.87
(0.09)
0.15
(0.12)
In order to examine this trend,
we classified the individuals into
two groups- those with maximum
CMB grades _<III and >Ill.
Distribution by maximum CMB
grade is given in Table 3.
Table 3. Individual Characters by
Maximum Grade of CMB
>m _<m
nffi31 nffi28
Age (years)
BMI
TR_
Time to
CMB (rain)
32.2
(6.3)
23.7
(1.9)
1.73
(0.07)
59.3
(51.9)
30.1
(5.0)
23.7
(1.9)
1.69
(0.11)
105.8 *
(63.5)
Values are Mean (S.D.); *P<0.05
The risk of DCS in the presence
of higher grades of microbubbles
was examined by calculating the
relative risk values (5). Cox
proportional hazards regression
was used to adjust for various
other factors such as age, BMI,
TR3eo and time to detection of
CMB. The results of this analysis
are given in Table 4.
Table 4. Relative Risk of
Symptoms of DCS
CMB
Grade
..<III
>III
DCS Crude Adjusted
Yes No RR RR*
4 24 1.00 1.00
11 20 4.52*
(1.76-11.61)
2.46*
(1.26-5.34)
RR=Relative Risk; 95% confidence
intervals in parentheses
*P<0.01
+Adjusted for age, BMI, TR360, and time
to detection of CMB in the Cox
proportional hazards regression model.
These results showed that
individuals with greater than
grade Ill CMB were at increased
risk of symptoms.
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Discussion:
Before examining the
association between CMB and
symptoms of altitude DCS, two
important issues must be
considered. They are:
* cause and effect
* censoringofinformation
Although microbubbles occur
during decompression, their
relationship to symptoms may not
be causal. This is especially a
problem in case of bends pain. The
pain of bends is thought to be due
to the formation of free gas
microbubbles in extravascular
tissues (2), as opposed to the
intravascular circulating micro-
bubbles detected by the precorclial
Doppler. However, this data could
be used in a predictive manner to
monitor the development of
symptoms of DCS (6). This
information is usually censored, so
not amenable to traditional
methods of analysis.
Survival analysis is useful
under these circumstances. The
distribution of survival times is
divided into a certain number of
intervals. For each interval, the
proportion with symptoms (or any
"event"),and the proportion that
were lostor censored are obtained.
Then the cumulative proportion of
cases surviving through each
interval is calculated. In the
product-limit method, the
cumulative proportion thus
obtained is a maximum likelihood
estimate (3,4).
Utilizing survival analysis we
found that individuals with
Spencer grade IV CMB showed
2.46 times higher risk of
symptoms, compared to individuals
with lower grades. This risk was
unchanged, even aider adjusting
for the influence of other variables
in the regression model.
There are several implications
from these results. Neurological
symptoms and other severe
complications of DCS are main
concerns under space EVAs. While
ground-based studies indicate a.
10% to 20% risk of minor DCS
symptoms, no cases have b_eh
reported from space EVAs.
Several steps have been taken
to examine this "decompression
anomaly" in space. Our analysis
showed increased risk of DCS with
higher CMB grades during
simulated EVA profiles. This
findingWould provide a strong case
for inflight precordial Doppler
monitoring of astronauts in the
space suit during space EVA.
Further, this finding would permit
definitionof a high risk group for
DCS, based on the obtained
information on CMB. A program
for meeting these objectives is
currently being developed at this
Laboratory.
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